Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis
Phase 4
Completed
- Conditions
- Gingivitis
- Interventions
- Drug: Stannous Fluoride ToothpasteDrug: Colgate fluoride toothpaste
- Registration Number
- NCT05731778
- Lead Sponsor
- Colgate Palmolive
- Brief Summary
Evaluate a stannous technology for its effect on the neutrophil phenotype during an induced gingivitis state.
- Detailed Description
A 9-weeks clinical study will be conducted to evaluate a stannous fluoride dentifrice for therapeutic effects that aim to delay the onset of experimental gingivitis as well as hasten the resolution of disease.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
- Male or female volunteers aged 18-70 years
- In good general health, ASA I
- No clinical signs of gingival inflammation at >90% sites observed
- Probing Depth (PD) < 3.0 mm
- Attachment Loss (AL) = 0 mm
- No periodontal disease history
- Non-smokers
- Fluent in English
Exclusion Criteria
- Presence of orthodontic bands.
- Presence of partial removal dentures.
- Tumour(s) of the soft or the hard tissues of the oral cavity.
- Cavitated carious lesions requiring immediate restorative treatment.
- History of allergy to consumer or personal care products or dentifrice ingredients as determined by the dental profession monitoring the study.
- Participation in any other clinical study or test panel with a one month period prior to entering the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Stannous fluoride test toothpaste Stannous Fluoride Toothpaste Currently marketed as the new Colgate Total SF containing Stannous Fluoride Colgate flouride toothpaste Colgate fluoride toothpaste Colgate Dental Cream containing Stannous Sodium Fluoride
- Primary Outcome Measures
Name Time Method Bleeding Index (BOP) and Oral Inflammatory Load during patient visit over the 9 weeks BOP is a bleeding index standard in field, oral inflammatory load as measured by neutrophil levels in oral rinses
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Toronto
🇨🇦Toronto, Ontario, Canada